MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL‐Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling PathwayYuxin Wang, Fengchao Zhao|Oxidative Medicine and Cellular Longevity|2022Cited by 11